Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)
| Market Cap | 1.75B+8.7% |
| Revenue (ttm) | 106.73M+60.7% |
| Net Income | -149.87M-25.1% |
| EPS | -2.67+27.6% |
| Shares Out | 59.56M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 294,072 |
| Open | 28.95 |
| Previous Close | 28.76 |
| Day's Range | 28.52 - 29.64 |
| 52-Week Range | 17.34 - 30.00 |
| Beta | 0.62 |
| Analysts | Buy |
| Price Target | 31.50(+7.07%) |
| Earnings Date | Dec 10, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About KMTS
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating KMTS in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 10, 2026Earnings report
Ask Barron about KMTS
$KMTS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in KMTS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by KMTS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
KMTS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New KMTS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to KMTS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in KMTS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $26.23M |
| IWMiShares Russell 2000 ETF | $19.44M |
| VXFVanguard Extended Market ETF | $10.53M |
| IWOiShares Russell 2000 Growth ETF | $7.12M |
| FYCFirst Trust Small Cap Growth AlphaDEX Fund | $6.96M |
| SCHASchwab U.S. Small-Cap ETF | $5.06M |
Estimated from each fund’s disclosed top holdings × AUM
KMTS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from KMTS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score